---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-027445"
form_type: "8-K"
ticker: "PRPH"
cik: "0000868278"
company_name: "ProPhase Labs, Inc."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T20:55:21.806136+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ProPhase Labs Q2 revenue $13.2M, down 55% YoY; adjusted EBITDA loss $2.2M

## Summary
- Revenue $13.2M vs $29.1M YoY; diagnostic services fell $18.3M as COVID testing slowed.
- Gross margin fell to 48.8% from 64.3%; net working capital $40.2M.
- Nebula Genomics whole genome sequencing facility could generate ~$40M annual revenue at capacity.
- Pharmaloz Manufacturing revenue up >50% YoY; additional lozenge line planned for early 2024.
- Equivir trial enrollment commenced in India; BE-SMART test progressed with over 200 specimens.

## SEC filing metadata
- accession: 0001493152-23-027445
- form_type: 8-K
- ticker: PRPH
- cik: 0000868278
- company_name: ProPhase Labs, Inc.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/868278/000149315223027445/0001493152-23-027445-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/868278/000149315223027445/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-027445
- JSON: https://secwatch.observer/filing/0001493152-23-027445.json
- Plain text: https://secwatch.observer/filing/0001493152-23-027445.txt

## Key facts
- Earnings Releases
  ProPhase Labs, Inc. reported the three months ended June 30, 2023 results: net income adjusted EBITDA loss for the quarter ended June 30,2023 was $2.2 million.
  - Period: the three months ended June 30, 2023
  - Net income: adjusted EBITDA loss for the quarter ended June 30,2023 was $2.2 million
  - Result: reported results
  source text: On August 10, 2023, ProPhase Labs, Inc. (the “Company”) issued a press release announcing its financial results for the second quarter ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/868278/000149315223027445/0001493152-23-027445-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.